The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...

The Federal Trade Commission (FTC) on September 27, 2024 unexpectedly withdrew from a recently established Memorandum of Understanding (MOU) with ...

By Andy Miller, KFF Health News. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities have drawn scrutiny from Congress, the Federal Trade Commission, and ...

Ohioans must recognize the threat that vertically-integrated insurance conglomerates pose to our health and pocketbooks.

Nationally, criticism of PBM practices intensified over the summer with the FTC report. The PCMA pushed back, saying the report "is based on anecdotes and comments from anonymous sources and ...

Nationally, criticism of PBM practices intensified over the summer with the FTC report. The PCMA pushed back, saying the report "is based on anecdotes and comments from anonymous sources and self ...

The PBM profit "is going to line people's pockets ... Bell's Family Pharmacy closed earlier this year. The FTC sued three of the largest PBMs — Caremark, Express Scripts, and Optum Rx, which ...

FTC Chairwoman Lina Khan, with her fellow Democratic Commissioners, recently filed a suit against the leading PBMs in an effort to undermine, or even prohibit, their use of rebates to secure ...